Social Media Wiki

Social Media: More Questions Than Answers?

First, a little housekeeping before we jump into the post. Some of you may have heard (via this post I wrote on my personal blog) that I was leaving Bridge Worldwide and would no longer be writing for Dose of Digital. After that, you then may have heard that I wasn’t leaving Bridge after all, as they did all they could and successfully lured me back (see that post here).

Net result: I’m still writing Dose of Digital, but I’ll also be in a slightly different position here as the newly created Director of Social Media for the agency. I’m pretty excited about it…stay tuned for more updates on some of the really cool blogging we’ll be doing, which will be completely focused on social media across all industries (not just pharma and healthcare). That’ll be coming soon. If you want to be alerted when it’s ready, sign up using the form at the bottom of the post and we’ll send you an email. I’ll also post something on Dose of Digital to let everyone know.

If you hadn’t heard anything about me leaving Bridge and then coming back, then you can pretend like the last two paragraphs didn’t happen.

And now on with the show…

__________

Since I’ll be focusing even more on social media moving forward, I’ve been thinking more about the medium than usual. In doing this, I’ve realized one thing when it comes to social media: people seem to have more questions than answers.

Some of the questions are big, philosophical ones like: do consumers even want us engaging with them via social media?

Other questions are very business specific like: how in the world are we going to measure the ROI of our Twitter feed?

And some others focus on the tiny details that make us all a little crazy such as: if you used to be able to “Fan” a Page in Facebook and we called people “Fans,” what do we call people who now choose to “Like” our page? Likers? Likes? (I’ll answer that in one of my first posts on the new blog, BTW).

All good questions and somehow they create even more questions as you dig in a little deeper. Point is, just when you think you know it all when it comes to social media, you don’t. And even when you think you at least know all the questions (i.e., you know what you don’t know), something new comes along that changes everything.

I’m sure at this point you’re expecting me to give you the answers to the questions above and a few more. Sorry, I’m not going to do that.

The reality is that there are no simple answers to these questions and many others. Yes, there are some answers and some really good ideas about each, but some questions don’t have any absolutes. I’m going to do my best to answer these questions in the coming weeks and months, but I’ll look to each of you to help. Since there are no absolutes, that means there’s a lot of gray area and a lot of room for interpretation. That’s good and bad, as I plan to demonstrate.

Of course, I just gave you three questions. There are millions more out there about social media that need answers. Some of them have been answered sufficiently in the past, but others still need a little clarity.

So, since we’re talking social media, let’s use it. What questions about social media do you have? They don’t need to relate to pharma or healthcare; they can be general. I’ll take all of these questions and in the coming weeks will do my best to answer every one of them. I’ll probably look to some of you for a bit if this exercise becomes really popular.

How do you submit your question? Simple. You have two options.

Choice 1: Scroll down to the comment form at the end of the post (and all the other comments) and type it in. I’ll answer them all either in the comments or, for bigger issues, as a future blog post. In addition, I’d invite every reader to also give your answers to the questions as well.

Choice 2: Submit your question to the discussion section of the Dose of Digital Page on Facebook. If you want the 530+ Dose of Digital “Facebook Nation” to take a shot at your question and to spark an interesting  and likely contentious debate, then that might be the best option for you. PS: Don’t forget to “Like” the page when you get there.

I’m looking forward to an interesting discussion. If you’ve ever had a question about social media that you wanted answered, here’s your chance.

Fill in this form to be alerted when we start up our new social media blog.

(PS: You’ll only get the one email when we launch, unless you opt in (by checking the box) for some other things.)

* indicates required

Subscribe to the Dose of Digital RSS Feed


Join
Dose of Digital on Facebook for exclusive content and sneak previews.



Ready to hire the folks behind Dose of Digital? Contact us.

Possibly related posts (auto-generated):

  1. A Sneak Preview of My FDA Social Media Hearing Testimony
  2. How Pharma Overcomplicates Social Media
  3. Pharma and Healthcare Social Media Wiki Live


Print This Post Print This Post

  • http://topsy.com/trackback?utm_source=pingback&utm_campaign=L2&url=http://www.doseofdigital.com/2010/06/social-media-questions-answers/ Tweets that mention Social Media: More Questions Than Answers?” Submit your question for Dose of Digital to answer. Plz RT — Topsy.com

    [...] This post was mentioned on Twitter by Jonathan Richman, Jonathan Richman. Jonathan Richman said: "Social Media: More Questions Than Answers?" Submit your question for Dose of Digital to answer. Plz RT http://bit.ly/bk5uFP [...]

  • http://humanvoice.wordpress.com Tom O’Brien

    Hi Jonathan:

    Well, stranger things have happened than leaving and then getting pulled (persuaded) back in. Congrats on your expanded role.

    I’m going to answer (from my perspective) just one of your questions about SM. That is do people even want us (marketers) there?

    This is the crux of the challenge in SM. In fact I personally despise the name SM because it has the word “media” in it. This word immediately makes marketers think of it as yet one more channel in which to advertise at people.

    The great frustration (of marketers) with SM is that it turns out to be a terrible channel for marketing. That is because we (as consumers) are not engaging in SM to be marketed to. This (as you said) is an engagement channel, not a marketing channel.

    To engage requires the marketer to get off their pedestal and put people first. Stop trying to sell stuff to people and help them solve their problems. If you do that you might just get a little love back on the form of sales, advocacy, loyalty.

    This is an unnatural act for marketers, so only in the exception is this rule proven (see @Zappos).

    So, the answer is this. SM is a great engagement channel, but it is a lousy marketing channel. Engagement requires one to be helpful, human and humble and to subordinate their interests to the community interests.

    These are VERY hard things for marketers (corporations)to do.

    My $0.02.

    Tom O’Brien
    MotiveQuest LLC
    @tomob

  • http://@RealMcCoy1982 Mel McCoy

    Hi Jon,

    Congrats on the promotion! I must admit I’m a little bummed that the blog will no longer focus solely on healthcare, particularly because there are lots of blogs discussing social media in general. However, I do think that healthcare/pharma/biotech could do well to learn best practices from other industries that are already engaging heavily in social media.

    And to add to Tom’s comment — I respectfully disagree. I have found great products and services (Groupon being my personal favorite), and loads of helpful information via social media. Of course, I have ignored many, many, many ads and promotional tweets. I really appreciate social media for the proliferation of niche audiences and think that more than ever before marketing, advertising and PR professionals have a better chance at finding those folks who may embrace the service or endorse the product they are promoting (assuming that said product/service is sound).

  • http://www.doseofdigital.com Jonathan Richman

    Mel,

    Thanks for the kind words. Just to be clear, Dose of Digital will remain pharma and healthcare focused. The new blog I’m developing will be more general. Stay tuned.

    Jonathan

  • http://humanvoice.wordpress.com Tom O’Brien

    Hi Mel:

    We saw the CEO of Groupon at WOMMA conference last week in Chicago – and I am here to tell you that Groupon is another exception that proves the rule. They are suprisingly human and un-corporate in all of their interactions with people.

    Andrew Mason (CEO) walked on stage in front of 300 people wearing cargo shorts.

    I’m not saying SM isn’t a great way to engage with people – I’m saying it is a lousy way to advertise.

    Tom O’Brien